PPT-Difference Cancer Classifier Determine Cancer Genetic Alterations

ngs of biopsy specimen Molecular Cancer Classifier can Determine the Cancer Type but Not Genetic Alterations in Cancer Cells Comprehensive Profiling NGS Can Determine Genetic Alterations in Cancer Cells but Can Not Determine the Cancer. Raymond Kim. MD/PhD, FRCPC, FCCMG, FACMG. Medical Geneticist. Princess Margaret Cancer Centre. Outline. Genetic terminology and concepts. Hereditary cancers. When to consider. Genetics assessment. Surveillance. Kayla York, MS, LCGC. Licensed Genetic Counselor. Avera Cancer Institute. Outline . Genetic Counseling. Cancer Genetics. Breast/Ovarian Cancer. Colon/Endometrial Cancer . Summary. Genetic Counseling. Kristin . DePrince. Mattie, M.S.. Licensed / Certified Genetic Counselor. William G. Rohrer Cancer Genetics Program. Objectives. Describe . current approaches to genetic testing for hereditary cancer syndromes. http://. www.cbioportal.org/index.do. Web resource for exploring, visualizing, and analyzing . multidimentional. cancer genomics data. cBioPortal. : Purpose and Advantages. reduces. . molecular profiling data from cancer tissues and cell lines into readily understandable genetic, epigenetic, gene expression, and proteomic events. Ben Ho Park MD PhD. Johns Hopkins University. Financial Disclosures. I have financial relationships with commercial entities that are relevant to the content of this presentation.. Royalties from Horizon Discovery, LTD. About Cheryl Cina, MS, LCGCLicensed, Certied Genetic Poway, CA 92064 Laura . K. Fisher. , MS, CGC. Director . of Genetic . Counseling. October . 8, 2019. Outline. Genetic counseling. What happens at a genetic counseling appointment? . Who should see a genetic counselor?. North Dakota Cancer Coalition Cancer Conference. May 18, 2011. Marie Schuetzle, MS, CGC. Larissa Hansen, MS. Objectives. At the conclusion of this presentation, participants should be able to. Identify individuals at risk for hereditary cancer. cancer genomes. Matthew Meyerson, M.D., Ph.D.. Dana-Farber Cancer Institute. Harvard Medical School. Broad Institute. Bioconductor. Conference. Dana-Farber Cancer Institute. Boston, Massachusetts. July 31, 2014. Web resource for exploring, visualizing, and analyzing . multidimentional. cancer genomics data. cBioPortal. : Purpose and Advantages. reduces. . molecular profiling data from cancer tissues and cell lines into readily understandable genetic, epigenetic, gene expression, and proteomic events. 6311 Correspondence to:Christian Focan, MD, Ph.D., CHC; CliniqueSaint-Joseph, 75, rue de Hesbaye, B-4000-LIEGE, Belgium. Tel:+32 42248990, Fax: +32 42248991, e-mail: christian.focan@chc.beKey Words: C Patients in the Hereditary Cancer Network Database Background: Mutations in BRCA1 and BRCA2 genes increase an individual’s lifetime risk of breast cancer up to 80 percent, ovarian cancer up to 3 cyto. )genetics in a diagnostic setting. Basic technical aspects such as conventional karyotyping, methods and principles in fluorescence . in situ . hybridization (FISH), micro-array genomic profiling, QPCR, gene sequencing and new technologies such as Optical Genome Mapping and Whole Genome sequencing will be presented. In addition to the various laboratory techniques, there will be presentations on quality assessment, ISCN nomenclature and genetic aberrations in different types of leukemia. The program includes two panel discussions (for live audience only) in which participants will have the opportunity to ask questions and present their own patient cases.. Cori Chandler, MPA. Sr. Manager, State & Local Campaigns – Access to Care. Genetic Testing. 2. Genetic Testing. What is it?. The testing of a person’s germline genes. This testing is typically performed using biospecimens such as blood or cells.